CODX vs NSC · rev $3.9M vs P/E 18, rev $12.12B
Co-Diagnostics, Inc. Common Stock (CODX) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported NSC revenue for 2024-12-31 was $12.12B. Net income was $2.62B. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
CODX currently screens at market cap $31.4M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the CODX and NSC stock pages for the full models.
Not investment advice.